US tariffs could undo generic drugmakers' efforts to be less reliant on China Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 13 August, 2025

PharmaForceIQ’s real-time customer engagement platform helps you reimagine what’s possible—driving agile campaigns with such strong ROI that 100% of clients renew. sponsored by PharmaForceIQ

SPOTLIGHT Post-Hoc Live: Brett Giroir on what RFK's exile of mRNA means for biotech, vaccine trust and MAHA

news Treg biotech Abata Therapeutics closes as money runs short Autolus says it won’t make money from its cell therapy in Europe until 2027 US tariffs could undo generic drugmakers' efforts to be less reliant on Chinese raw materials, experts say Fertility startup Gameto raises $44M to fund Phase 3 study of stem cell IVF therapy

Principal - Life Science Alexandria Real Estate Equities San Francisco, CA, USA Senior Director of IT Caribou Biosciences, Inc. Berkeley, CA, USA Director Of Business Development, Health And Biomedical Innovation Brown University Providence, RI, USA Senior Patent Counsel Caribou Biosciences, Inc. Berkeley, CA, USA Head of Lab Operations Terray Therapeutics, Inc. Monrovia, CA, USA Principal Scientist, Molecular Design Terray Therapeutics, Inc. Monrovia, CA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Sep 04 11:00am ET Not just a tool: How AI agents become trial teammates sponsored by Medable Aug 21 2:00pm ET Agentic AI is here: Real-world applications in life sciences & healthcare sponsored by IBM

The biotech companies everyone will be talking about in 2025 get revealed live in Boston this September. Endpoints 11 isn’t just any list — it’s where industry insiders gather to see which bold bets might pay off. Find out who wins in real time at the State Room — reserve your spot now and save with the Early Bird rate.

ENDPOINTS PHARMA Summit, the hottest PD-1xVEGF biotech, is burning cash fast — but it may not be cause for alarm AbbVie details nearly $200M API plant as part of new US investments Insmed gets FDA approval for the first DPP1 inhibitor, in lung disease SEC charges Texas investor with insider trading after Cancer Genetics' 2020 merger Padcev-Keytruda combo shows 'compelling' survival results in Phase 3 bladder cancer trial

in case you missed it 1. Sarepta details Elevidys’ liver toxicity data and plans for safety study 2.